These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 26405628)

  • 21. Comparison of triple-negative and estrogen receptor-positive/progesterone receptor-positive/HER2-negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucose/positron emission tomography imaging parameters: a potentially useful method for disease characterization.
    Basu S; Chen W; Tchou J; Mavi A; Cermik T; Czerniecki B; Schnall M; Alavi A
    Cancer; 2008 Mar; 112(5):995-1000. PubMed ID: 18098228
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Distribution and prognosis of molecular breast cancer subtypes defined by immunohistochemical biomarkers in a Spanish population-based study.
    Puig-Vives M; Sánchez MJ; Sánchez-Cantalejo J; Torrella-Ramos A; Martos C; Ardanaz E; Chirlaque MD; Perucha J; Díaz JM; Mateos A; Machón M; Marcos-Gragera R
    Gynecol Oncol; 2013 Sep; 130(3):609-14. PubMed ID: 23747837
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The impact of molecular subtype on breast cancer recurrence in young women treated with contemporary adjuvant therapy.
    Alabdulkareem H; Pinchinat T; Khan S; Landers A; Christos P; Simmons R; Moo TA
    Breast J; 2018 Mar; 24(2):148-153. PubMed ID: 28707744
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Incidence and risk factors for breast cancer subtypes in three distinct South-East Asian ethnic groups: Chinese, Malay and natives of Sarawak, Malaysia.
    Devi CR; Tang TS; Corbex M
    Int J Cancer; 2012 Dec; 131(12):2869-77. PubMed ID: 22407763
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hormone receptor and HER2 status in patients with breast cancer by races in southeastern Turkey.
    Kuzhan A; Adli M; Eryigit Alkis H; Caglayan D
    J BUON; 2013; 18(3):619-22. PubMed ID: 24065473
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A population-based analysis of breast cancer incidence and survival by subtype in Ontario women.
    Seung SJ; Traore AN; Pourmirza B; Fathers KE; Coombes M; Jerzak KJ
    Curr Oncol; 2020 Apr; 27(2):e191-e198. PubMed ID: 32489268
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Subtype-Specific Breast Cancer Incidence Rates in Black versus White Men in the United States.
    Sung H; DeSantis C; Jemal A
    JNCI Cancer Spectr; 2020 Feb; 4(1):pkz091. PubMed ID: 32337499
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Everolimus plus Exemestane for Hormone Receptor-Positive Advanced Breast Cancer: A PAM50 Intrinsic Subtype Analysis of BOLERO-2.
    Prat A; Brase JC; Cheng Y; Nuciforo P; Paré L; Pascual T; Martínez D; Galván P; Vidal M; Adamo B; Hortobagyi GN; Baselga J; Ciruelos E
    Oncologist; 2019 Jul; 24(7):893-900. PubMed ID: 30679318
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association between county-level socioeconomic status and the incidence of and surgical treatment for pituitary adenoma.
    Cote DJ; Kruchko C; Barnholtz-Sloan JS; Zada G; Wiemels JL; Ostrom QT
    J Neurosurg; 2024 Mar; 140(3):724-734. PubMed ID: 37877990
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Breast Cancer Subtype Variation by Race and Ethnicity in a Diverse Population in British Columbia.
    Wan D; Villa D; Woods R; Yerushalmi R; Gelmon K
    Clin Breast Cancer; 2016 Jun; 16(3):e49-55. PubMed ID: 26454611
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neighborhood Disadvantage, African Genetic Ancestry, Cancer Subtype, and Mortality Among Breast Cancer Survivors.
    Iyer HS; Zeinomar N; Omilian AR; Perlstein M; Davis MB; Omene CO; Pawlish K; Demissie K; Hong CC; Yao S; Ambrosone CB; Bandera EV; Qin B
    JAMA Netw Open; 2023 Aug; 6(8):e2331295. PubMed ID: 37647068
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of NCI Socioeconomic Index on the Outcomes of Nonmetastatic Breast Cancer Patients: Analysis of SEER Census Tract-Level Socioeconomic Database.
    Abdel-Rahman O
    Clin Breast Cancer; 2019 Dec; 19(6):e717-e722. PubMed ID: 31519450
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Disparities in cancer incidence and mortality by area-level socioeconomic status: a multilevel analysis.
    Hastert TA; Beresford SA; Sheppard L; White E
    J Epidemiol Community Health; 2015 Feb; 69(2):168-76. PubMed ID: 25288143
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Breast Cancer Outcomes as Defined by the Estrogen Receptor, Progesterone Receptor, and Human Growth Factor Receptor-2 in a Multi-ethnic Asian Country.
    Subramaniam S; Bhoo-Pathy N; Taib NA; Tan GH; See MH; Jamaris S; Ho GF; Looi LM; Yip CH
    World J Surg; 2015 Oct; 39(10):2450-8. PubMed ID: 26138872
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Socioeconomic and racial disparities in the selection of chest wall boost radiation therapy in californian women after mastectomy.
    Hess C; Lee A; Fish K; Daly M; Cress RD; Mayadev J
    Clin Breast Cancer; 2015 Jun; 15(3):212-8. PubMed ID: 25499694
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HER3 status by immunohistochemistry is correlated with poor prognosis in hormone receptor-negative breast cancer patients.
    Bae SY; La Choi Y; Kim S; Kim M; Kim J; Jung SP; Choi MY; Lee SK; Kil WH; Lee JE; Nam SJ
    Breast Cancer Res Treat; 2013 Jun; 139(3):741-50. PubMed ID: 23722313
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular subtype predicts incidence and prognosis of brain metastasis from breast cancer in SEER database.
    Kim YJ; Kim JS; Kim IA
    J Cancer Res Clin Oncol; 2018 Sep; 144(9):1803-1816. PubMed ID: 29971531
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Breast cancer in Ethiopia: evidence for geographic difference in the distribution of molecular subtypes in Africa.
    Hadgu E; Seifu D; Tigneh W; Bokretsion Y; Bekele A; Abebe M; Sollie T; Merajver SD; Karlsson C; Karlsson MG
    BMC Womens Health; 2018 Feb; 18(1):40. PubMed ID: 29444670
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Trends in use of contralateral prophylactic mastectomy by racial/ethnic group and ER/PR status among patients with breast cancer: A SEER population-based study.
    Brown D; Shao S; Jatoi I; Shriver CD; Zhu K
    Cancer Epidemiol; 2016 Jun; 42():24-31. PubMed ID: 26999400
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Breast cancer survival by molecular subtype: a population-based analysis of cancer registry data.
    Fallahpour S; Navaneelan T; De P; Borgo A
    CMAJ Open; 2017 Sep; 5(3):E734-E739. PubMed ID: 28951445
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.